EcoR1 Capital as of Sept. 30, 2024
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 63 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 11.7 | $343M | 12M | 28.84 | |
| Anaptysbio Inc Common (ANAB) | 8.9 | $261M | 7.8M | 33.50 | |
| Crinetics Pharmaceuticals In (CRNX) | 7.5 | $219M | 4.3M | 51.10 | |
| Prothena Corp SHS (PRTA) | 6.6 | $194M | 12M | 16.73 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 6.5 | $190M | 1.7M | 111.41 | |
| Zymeworks Del (ZYME) | 5.8 | $169M | 13M | 12.55 | |
| Arvinas Ord (ARVN) | 5.7 | $166M | 6.7M | 24.63 | |
| Kura Oncology (KURA) | 3.9 | $114M | 5.8M | 19.54 | |
| Xencor (XNCR) | 3.7 | $107M | 5.3M | 20.11 | |
| Tango Therapeutics (TNGX) | 3.5 | $103M | 13M | 7.70 | |
| Janux Therapeutics (JANX) | 2.3 | $67M | 1.5M | 45.43 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.2 | $65M | 1.4M | 46.98 | |
| Immunome (IMNM) | 1.9 | $57M | 3.9M | 14.62 | |
| Neurogene (NGNE) | 1.8 | $53M | 1.3M | 41.96 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.8 | $52M | 3.2M | 15.99 | |
| Miragen Therapeutics (VRDN) | 1.5 | $45M | 2.0M | 22.75 | |
| Nuvation Bio Com Cl A (NUVB) | 1.5 | $44M | 19M | 2.29 | |
| Third Harmonic Bio (THRD) | 1.5 | $43M | 3.2M | 13.55 | |
| Vaxcyte (PCVX) | 1.4 | $40M | 353k | 114.27 | |
| Mersana Therapeutics | 1.3 | $37M | 19M | 1.89 | |
| Oric Pharmaceuticals (ORIC) | 1.2 | $35M | 3.4M | 10.25 | |
| Avidity Biosciences Ord (RNA) | 1.2 | $35M | 758k | 45.93 | |
| Edgewise Therapeutics (EWTX) | 1.1 | $33M | 1.3M | 26.69 | |
| Mbx Biosciences Com Added (MBX) | 1.0 | $31M | 1.2M | 25.98 | |
| Neumora Therapeutics (NMRA) | 0.9 | $27M | 2.1M | 13.21 | |
| Cargo Therapeutics (CRGX) | 0.9 | $27M | 1.5M | 18.45 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.9 | $26M | 27M | 0.95 | |
| Tectonic Therapeutic (TECX) | 0.9 | $26M | 849k | 30.30 | |
| Tscan Therapeutics (TCRX) | 0.9 | $25M | 5.0M | 4.98 | |
| Voyager Therapeutics (VYGR) | 0.8 | $23M | 3.9M | 5.85 | |
| Celldex Therapeutics Com New (CLDX) | 0.8 | $22M | 650k | 33.99 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $21M | 910k | 22.63 | |
| Ionis Pharmaceuticals (IONS) | 0.7 | $20M | 500k | 40.06 | |
| Dyne Therapeutics (DYN) | 0.7 | $20M | 556k | 35.92 | |
| Atea Pharmaceuticals (AVIR) | 0.6 | $18M | 5.4M | 3.35 | |
| Relay Therapeutics (RLAY) | 0.6 | $18M | 2.5M | 7.08 | |
| Pharvaris N V (PHVS) | 0.6 | $17M | 900k | 18.52 | |
| Iteos Therapeutics | 0.6 | $16M | 1.6M | 10.21 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $16M | 75k | 212.22 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $12M | 862k | 13.93 | |
| Keros Therapeutics (KROS) | 0.4 | $11M | 188k | 58.07 | |
| Replimune Group (REPL) | 0.3 | $9.3M | 850k | 10.96 | |
| Allovir (ALVR) | 0.3 | $9.1M | 11M | 0.81 | |
| Lenz Therapeutics (LENZ) | 0.3 | $8.2M | 347k | 23.74 | |
| Verve Therapeutics (VERV) | 0.2 | $6.1M | 1.3M | 4.84 | |
| Generation Bio | 0.2 | $5.1M | 2.0M | 2.47 | |
| Eton Pharmaceuticals (ETON) | 0.2 | $4.8M | 794k | 6.00 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $4.5M | 155k | 28.79 | |
| Bridgebio Pharma (BBIO) | 0.1 | $4.3M | 170k | 25.46 | |
| Atara Biotherapeutics Com New (ATRA) | 0.1 | $3.8M | 469k | 8.13 | |
| Aadi Bioscience (WHWK) | 0.1 | $3.8M | 1.8M | 2.06 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $3.3M | 1.8M | 1.82 | |
| Prime Medicine (PRME) | 0.1 | $2.7M | 700k | 3.87 | |
| Hookipa Pharma Com New Added (HOOK) | 0.1 | $2.5M | 572k | 4.30 | |
| Aligos Therapeutics Com New Added (ALGS) | 0.1 | $2.2M | 256k | 8.66 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $2.2M | 963k | 2.29 | |
| Kyverna Therapeutics (KYTX) | 0.1 | $2.2M | 450k | 4.89 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $799k | 67k | 11.98 | |
| Artiva Biotherapeutics Com Added (ARTV) | 0.0 | $640k | 42k | 15.45 | |
| Design Therapeutics (DSGN) | 0.0 | $290k | 54k | 5.38 | |
| Macrogenics (MGNX) | 0.0 | $184k | 56k | 3.29 | |
| Caremax *w Exp 06/08/202 | 0.0 | $170k | 100k | 1.70 | |
| Allakos | 0.0 | $126k | 192k | 0.65 |
